Safer nicotine wiki

SNP recommendation guidelines: Difference between revisions

← Older edit
VisualWikitext
m NZ summary (also limited counter indicators)
PRI
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
Some countries and medical organizations have provided recommendations on which tobacco treatment cases might benefit from safer nicotine products as cessation option.
Medical organizations in some countries have provided recommendations on which tobacco treatment cases might benefit from safer nicotine products as cessation pathway.


== Canada ==
== Canada ==
Line 5: Line 5:
=== Lower-Risk Nicotine Use Guidelines (LRNUG) ===
=== Lower-Risk Nicotine Use Guidelines (LRNUG) ===
{| class="wikitable"
{| class="wikitable"
|+
!
!
|-
|Link
|Link
|https://www.nicotinedependenceclinic.com/en/lower-risk-nicotine-user-guidelin-es
|https://www.nicotinedependenceclinic.com/en/lower-risk-nicotine-user-guidelin-es
Line 27: Line 31:
===  NICE guidelines (NG209) ===
===  NICE guidelines (NG209) ===
{| class="wikitable"
{| class="wikitable"
|+
!
!
|-
|Link
|Link
|https://www.nice.org.uk/guidance/ng209
|https://www.nice.org.uk/guidance/ng209
Line 41: Line 49:
* Devices regulated according to EU TDP, notified to MHRA, covered under GPSR.
* Devices regulated according to EU TDP, notified to MHRA, covered under GPSR.
* Not currently licensed as medicines.
* Not currently licensed as medicines.
* People who smoke but can't/won't quit. can reduce harm by smoking less or substituting temporarily. Harm reduction benefits are uncertain, but may inspire full quitting.
* People who smoke but can't/won't quit. can reduce harm by smoking less or substituting temporarily.
* Harm reduction benefits are uncertain, but may inspire full quitting.
|-
|See also
|[https://www.gov.uk/government/publications/nicotine-vaping-in-england-2022-evidence-update Nicotine vaping in England: 2022 evidence update]
|}
|}


Line 47: Line 59:


{| class="wikitable"
{| class="wikitable"
|+
!
!
|-
|Link
|Link
|https://www.nhs.uk/live-well/quit-smoking/using-e-cigarettes-to-stop-smoking/
|https://www.nhs.uk/live-well/quit-smoking/using-e-cigarettes-to-stop-smoking/
Line 70: Line 86:
=== Vaping products: Information for health care workers and stop-smoking services ===
=== Vaping products: Information for health care workers and stop-smoking services ===
{| class="wikitable"
{| class="wikitable"
|+
!
!
|-
|Link
|Link
|https://www.health.govt.nz/our-work/preventative-health-wellness/tobacco-control/tobacco-control-information-practitioners/vaping-products-information-health-care-workers-and-stop-smoking-services
|https://www.health.govt.nz/our-work/preventative-health-wellness/tobacco-control/tobacco-control-information-practitioners/vaping-products-information-health-care-workers-and-stop-smoking-services
Line 97: Line 117:
=== VapingFacts ===
=== VapingFacts ===
{| class="wikitable"
{| class="wikitable"
|+
!
!
|-
|Link
|Link
|https://vapingfacts.health.nz/vaping-to-quit-smoking/
|https://vapingfacts.health.nz/vaping-to-quit-smoking/
Line 114: Line 138:
* Vaping is almost twice as effective as NRTs.
* Vaping is almost twice as effective as NRTs.
* Goal: reducing the strength of your nicotine.
* Goal: reducing the strength of your nicotine.
|}
== Australia ==
=== Nicotine vaping products: Information for prescribers ===
{| class="wikitable"
|+
!
!
|-
|Link
|https://www.tga.gov.au/resources/resource/guidance/nicotine-vaping-products-information-prescribers
|-
|Audience
|GPs / PWS
|-
|By
|Therapeutic Goods Administration
|-
|Considerations
|
* NVPs are Schedule 4 (prescription only) medicines, but remain 'unapproved'.
* Their potential efficacy for smoking cessation is currently mixed.
* [https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/supporting-smoking-cessation/tobacco-harm-reduction RACGP guideliness] apply, and NVPs are '''not first line treatment''' for smoking cessation.
* Availability hinges on authorised prescriber, special access, or personal importation scheme.
* TGA has a [https://www.tga.gov.au/resources/resource/guidance/authorised-prescribers-unapproved-nicotine-vaping-products list of authorised prescribers] (GPs).
|}
== US ==
=== PRI: Position on Vaping / Harm Reduction ===
{| class="wikitable"
|+
!
!
|-
|Link
|https://www.physiciansresearchinstitute.org/harm-reduction/
|-
|Audience
|GPs
|-
|By
|Physicians Research Institute
|-
|Considerations
|
* Today’s cigarattes are more difficult to quit. Standard treatment has a noticeable failure rate.
* Physicians misperceive the relative risks of nicotine in comparison to combustion.
* NVPs are a legal alternative, 20 times less harmful than continued smoking.
* Switching measurably reduces harm, and might even help even those not intending to quit.
|}
|}
Retrieved from "https://safernicotine.wiki/mediawiki/index.php/SNP_recommendation_guidelines"